| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | -$42.5M | ROE | −54.42% |
| Net Margin | — | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $50.3M | Trading Days | 487 |
| 52W High | 2.37 |
| 52W Low | 0.49 |
| % Off High | −77.16% |
| YTD | −45.86% | 1Y | −71.05% |
| Since incept. (ann.) | −59.70% |
| Ann. Volatility (1Y) | 86.37% | Ann. Volatility (3Y) | 127.17% |
| Sharpe (1Y) | −1.03 | Sharpe (3Y) | −0.13 |
| Max Drawdown (1Y) | −77.69% | Max Drawdown (3Y) | −90.68% |
| Beta (3Y, vs SPY) | 7.01 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| DWTX | Dogwood Therapeutics, Inc. | $52.1M | — |
| GOSS | Gossamer Bio, Inc. | $48.1M | — |
| CPHI | CHINA PHARMA HOLDINGS, INC. | $52.7M | — |
| XLO | Xilio Therapeutics, Inc. | $52.9M | — |
| RANI | Rani Therapeutics Holdings, Inc. | $54.2M | — |
| CNTX | Context Therapeutics Inc. | $54.3M | — |
| TCRT | Alaunos Therapeutics, Inc. | $46.4M | — |
| IBO | IMPACT BIOMEDICAL INC. | $46.4M | — |
| BHST | BIOHARVEST SCIENCES INC. | $46.2M | — |
| MCRB | Seres Therapeutics, Inc. | $46.0M | 7.5 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. |
| $55.1M |
| — |
| BOLD | Boundless Bio, Inc. | $55.5M | — |
